RE:Stay tunedA generic version fo Egrifta would still need to be approved by the FDA and no firm has as yet indicated they are going to try to get that approval. Also, I believe there is some FDA rle that makes it difficult to pursue such a generic approval while the FDA is considering a new version of the drug. While the F8 version has yet to be resubmitted, I suspect the FDA is still considered to be in the process of reviewing it as it awaits THTX's resubmission. But I could be wrong about it.
Bootleg versions of Egrifta have apparently been around for a long time and I believe this is what body builders are likely to use as the cost of Egrifta is prohibitive for almost all such potential users.